Each clinical study has its own guidelines for who may participate, called eligibility criteria.

Additional eligibility requirements:

• Be diagnosed with stage I-III cancer (melanoma, multiple myeloma, unstaged cancer are not eligible to participate)
• Currently receiving systemic treatment (e.g., chemotherapy, radiation or immunotherapy), have completed systemic treatment within the past 6 months, or have a treatment plan that includes upcoming systemic treatment
• Are experiencing at least a moderate level of anxiety
• Have access to a smartphone or tablet
• Fluent in English